These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27611330)

  • 1. Novel psychoactive substances: An investigation of temporal trends in social media and electronic health records.
    Kolliakou A; Ball M; Derczynski L; Chandran D; Gkotsis G; Deluca P; Jackson R; Shetty H; Stewart R
    Eur Psychiatry; 2016 Oct; 38():15-21. PubMed ID: 27611330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deaths of individuals aged 16-24 years in the UK after using mephedrone.
    Loi B; Corkery JM; Claridge H; Goodair C; Chiappini S; Gimeno Clemente C; Schifano F
    Hum Psychopharmacol; 2015 Jul; 30(4):225-32. PubMed ID: 26216555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Web search query data in testing theoretical assumptions about mephedrone.
    Kapitány-Fövény M; Demetrovics Z
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited use of novel psychoactive substances in South London nightclubs.
    Wood DM; Hunter L; Measham F; Dargan PI
    QJM; 2012 Oct; 105(10):959-64. PubMed ID: 22718853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, "meow meow") in the United Kingdom.
    Schifano F; Corkery J; Ghodse AH
    J Clin Psychopharmacol; 2012 Oct; 32(5):710-4. PubMed ID: 22926609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences.
    Karila L; Billieux J; Benyamina A; Lançon C; Cottencin O
    Brain Res Bull; 2016 Sep; 126(Pt 1):61-67. PubMed ID: 26995278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence and psychosis with 4-methylmethcathinone (mephedrone) use.
    Bajaj N; Mullen D; Wylie S
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply.
    McElrath K; O'Neill C
    Int J Drug Policy; 2011 Mar; 22(2):120-7. PubMed ID: 21242082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.
    Freeman TP; Morgan CJ; Vaughn-Jones J; Hussain N; Karimi K; Curran HV
    Addiction; 2012 Apr; 107(4):792-800. PubMed ID: 22257011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel psychoactive drug use among younger adults involved in US nightlife scenes.
    Kelly BC; Wells BE; Pawson M; Leclair A; Parsons JT; Golub SA
    Drug Alcohol Rev; 2013 Nov; 32(6):588-93. PubMed ID: 23795887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users.
    Homman L; Seglert J; Morgan MJ
    Psychopharmacology (Berl); 2018 Sep; 235(9):2609-2618. PubMed ID: 29946859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of 2 Populations of Mephedrone Abusers by Hair Testing. Application to 4 Forensic Expertises.
    Kintz P
    Curr Neuropharmacol; 2017; 15(5):658-662. PubMed ID: 27784226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Psychiatric Characteristics of People on a Mephedrone ("bath salts") Binge.
    Ordak M; Nasierowski T; Muszynska E; Bujalska-Zadrozny M
    Subst Use Misuse; 2020; 55(10):1610-1617. PubMed ID: 32306799
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimisation of methadone treatment in a group of patients on a mephedrone binge and dependent on many psychoactive substances.
    Ordak M; Nasierowski T; Muszynska E; Bujalska-Zadrozny M
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):38-42. PubMed ID: 31663415
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the 'benzofuran' compounds. A report from the United Kingdom National Poisons Information Service.
    Kamour A; James D; Lupton DJ; Cooper G; Eddleston M; Vale A; Thompson JP; Thanacoody R; Hill SL; Thomas SH
    Clin Toxicol (Phila); 2014 Dec; 52(10):1025-31. PubMed ID: 25345418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A web-based survey on mephedrone.
    Carhart-Harris RL; King LA; Nutt DJ
    Drug Alcohol Depend; 2011 Oct; 118(1):19-22. PubMed ID: 21420252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service.
    James D; Adams RD; Spears R; Cooper G; Lupton DJ; Thompson JP; Thomas SH;
    Emerg Med J; 2011 Aug; 28(8):686-9. PubMed ID: 20798084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mephedrone, new kid for the chop?
    Winstock AR; Mitcheson LR; Deluca P; Davey Z; Corazza O; Schifano F
    Addiction; 2011 Jan; 106(1):154-61. PubMed ID: 20735367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
    Sande M
    Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.
    Dargan PI; Albert S; Wood DM
    QJM; 2010 Nov; 103(11):875-9. PubMed ID: 20675396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.